Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;26(23):2100510.
doi: 10.2807/1560-7917.ES.2021.26.23.2100510.

Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021

Jochem B Buil  1 , Arthur R H van Zanten  2 , Robbert G Bentvelsen  3   4 , Tom A Rijpstra  5 , Bram Goorhuis  6 , Sanne van der Voort  6 , Linda J Wammes  4 , Jeroen A Janson  7 , Max Melchers  2 , Moniek Heusinkveld  8 , Willem J G Melchers  1 , Ed J Kuijper  4   9 , Paul E Verweij  1   9
Affiliations

Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021

Jochem B Buil et al. Euro Surveill. 2021 Jun.

Abstract

We describe four secondary fungal infections caused by Mucorales species in COVID-19 patients. Three COVID-19 associated mucormycosis (CAM) occurred in ICU, one outside ICU. All were men aged > 50 years, three died. Clinical presentations included pulmonary, rhino-orbital cerebral and disseminated infection. Infections occurred in patients with and without diabetes mellitus. CAM is an emerging disease and our observations underscore the need to be aware of invasive mucormycosis, including in COVID-19 patients without (poorly controlled) diabetes mellitus and outside ICU.

Keywords: COVID-19; invasive mucormycosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

References

    1. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. ISARIC4C investigators . Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. 10.1136/bmj.m1985 - DOI - PMC - PubMed
    1. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. the Northwell COVID-19 Research Consortium . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052-9. 10.1001/jama.2020.6775 - DOI - PMC - PubMed
    1. Alanio A, Dellière S, Fodil S, Bretagne S, Mégarbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020;8(6):e48-9. 10.1016/S2213-2600(20)30237-X - DOI - PMC - PubMed
    1. White PL, Dhillon R, Cordey A, Hughes H, Faggian F, Soni S, et al. A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU. Clin Infect Dis. 2020;ciaa1298. - PMC - PubMed
    1. Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, et al. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis. 2020;ciaa1065. - PMC - PubMed

LinkOut - more resources